JP2023518422A5 - - Google Patents

Info

Publication number
JP2023518422A5
JP2023518422A5 JP2022556046A JP2022556046A JP2023518422A5 JP 2023518422 A5 JP2023518422 A5 JP 2023518422A5 JP 2022556046 A JP2022556046 A JP 2022556046A JP 2022556046 A JP2022556046 A JP 2022556046A JP 2023518422 A5 JP2023518422 A5 JP 2023518422A5
Authority
JP
Japan
Prior art keywords
nitrogen
sulfur
oxygen
independently selected
heteroatoms independently
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022556046A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023518422A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/022794 external-priority patent/WO2021188696A1/en
Publication of JP2023518422A publication Critical patent/JP2023518422A/ja
Publication of JP2023518422A5 publication Critical patent/JP2023518422A5/ja
Pending legal-status Critical Current

Links

JP2022556046A 2020-03-17 2021-03-17 Stat分解剤およびそれらの使用 Pending JP2023518422A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US202062990555P 2020-03-17 2020-03-17
US62/990,555 2020-03-17
US202063088945P 2020-10-07 2020-10-07
US63/088,945 2020-10-07
US202063123335P 2020-12-09 2020-12-09
US63/123,335 2020-12-09
US202163159102P 2021-03-10 2021-03-10
US63/159,102 2021-03-10
PCT/US2021/022794 WO2021188696A1 (en) 2020-03-17 2021-03-17 Stat degraders and uses thereof

Publications (2)

Publication Number Publication Date
JP2023518422A JP2023518422A (ja) 2023-05-01
JP2023518422A5 true JP2023518422A5 (cg-RX-API-DMAC7.html) 2024-03-29

Family

ID=77771311

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022556046A Pending JP2023518422A (ja) 2020-03-17 2021-03-17 Stat分解剤およびそれらの使用

Country Status (9)

Country Link
US (1) US20240016942A1 (cg-RX-API-DMAC7.html)
EP (1) EP4121055A4 (cg-RX-API-DMAC7.html)
JP (1) JP2023518422A (cg-RX-API-DMAC7.html)
CN (1) CN115776891A (cg-RX-API-DMAC7.html)
AU (1) AU2021238333A1 (cg-RX-API-DMAC7.html)
CA (1) CA3170503A1 (cg-RX-API-DMAC7.html)
IL (1) IL296334A (cg-RX-API-DMAC7.html)
MX (1) MX2022011437A (cg-RX-API-DMAC7.html)
WO (1) WO2021188696A1 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020205467A1 (en) 2019-03-29 2020-10-08 The Regents Of The University Of Michigan Stat3 protein degraders
KR102980990B1 (ko) 2019-04-05 2026-06-25 카이메라 쎄라퓨틱스 인코포레이티드 Stat 분해제 및 이의 용도
CN115677831B (zh) * 2021-07-22 2026-03-17 杭州和正医药有限公司 拟肽类stat降解药物、组合物及应用
CA3239730A1 (en) * 2021-12-11 2023-06-15 Christopher De Savi Stat3 degraders and uses thereof
IL316050A (en) * 2022-03-31 2024-11-01 Recludix Pharma Inc STAT modulators and their uses
WO2023250058A1 (en) * 2022-06-22 2023-12-28 Kymera Therapeutics, Inc. Stat degraders and uses thereof
EP4565567A1 (en) * 2022-08-05 2025-06-11 Kymera Therapeutics, Inc. Deuterated stat3 degraders and uses thereof
US20260226086A1 (en) * 2023-02-13 2026-08-06 Regents Of The University Of Michigan Compounds and compositions as stat3 degraders and uses thereof
WO2024173298A1 (en) * 2023-02-13 2024-08-22 Regents Of The University Of Michigan Compounds and compositions as stat3 degraders and uses thereof
WO2024233639A2 (en) * 2023-05-09 2024-11-14 Recludix Pharma, Inc. Stat degraders and uses thereof
WO2024238603A2 (en) * 2023-05-15 2024-11-21 Recludix Pharma, Inc. Stat degraders and uses thereof
WO2024263673A1 (en) * 2023-06-20 2024-12-26 Regents Of The University Of Michigan Compounds and compositions as vhl ligands and stat3 degraders uses thereof
CN117024254B (zh) * 2023-08-10 2025-09-09 浙江大学衢州研究院 一种多氟苯酚的合成方法
WO2026007994A1 (zh) * 2024-07-03 2026-01-08 正大天晴药业集团股份有限公司 膦酸化合物及其用途
US20260042788A1 (en) * 2024-07-19 2026-02-12 Gilead Sciences, Inc. Stat6 compounds
WO2026027675A1 (en) 2024-07-31 2026-02-05 Guerra Gonzalez Carmen Triple combination for use in the treatmet of cancer

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2020003190A (es) * 2017-09-22 2020-11-11 Kymera Therapeutics Inc Degradadores de proteinas y usos de los mismos.
KR20220009941A (ko) * 2019-03-26 2022-01-25 더 리젠츠 오브 더 유니버시티 오브 미시간 Stat3의 저분자 분해제
WO2020205467A1 (en) * 2019-03-29 2020-10-08 The Regents Of The University Of Michigan Stat3 protein degraders
KR102980990B1 (ko) * 2019-04-05 2026-06-25 카이메라 쎄라퓨틱스 인코포레이티드 Stat 분해제 및 이의 용도

Similar Documents

Publication Publication Date Title
JP2022527114A5 (cg-RX-API-DMAC7.html)
TWI297335B (en) Taxol enhancer compounds
JP2023545730A5 (cg-RX-API-DMAC7.html)
JP6929234B2 (ja) 医薬共結晶組成物及びその用途
AU2009308511B2 (en) Transition metal complexes of a bis[thiohydrazide amide] compound
CN106794362B (zh) 用于治疗应用的一氧化碳-释放分子及其制备和使用方法
CA2909620C (en) Staple and suture polypeptides and their uses
CA2742388C (en) Thiolated paclitaxels for reaction with gold nanoparticles as drug delivery agents
JP6851989B2 (ja) 医薬用共結晶及びその用途
US20260124310A1 (en) Methods and materials for modulating nrf2 pathway
WO2019222349A1 (en) Compounds for treating dengue virus infections and other infections
CN100351233C (zh) E-异构体的富勒烯衍生物
JP6768716B2 (ja) カルボプラチンベースの共結晶の医薬組成物及びその用途
CA3115103A1 (en) Pi3k inhibitors and uses thereof
CN108473449B (zh) 一种作为吲哚胺-2,3-双加氧酶抑制剂的砜脒及其制备方法和用途
JP2004359546A (ja) ヒドロキサム酸誘導体、それらの非毒性塩およびそれらのプロドラッグ体を有効成分として含有する、固形癌の予防および/または治療剤
CN115611930A (zh) 具有高抗癌活性的新型锌(ii)配合物及其制备方法和应用
WO2022092295A1 (ja) βストランド型架橋ペプチド
JP7716147B2 (ja) 置換されたイソインドリン-1,3-ジオン類pde4阻害剤及びその薬物応用
KR102138415B1 (ko) 신규 peg 유도체
CN115340526B (zh) 邻二甲酰亚胺类化合物及其药物组合物、制备方法和用途
CA3092600A1 (en) Benzamide compound and preparation method, use, and pharmaceutical composition thereof
WO2019015689A1 (zh) 手性3-奎宁环酮类化合物、制备方法及用途
JP2023532878A (ja) ワクチンアジュバントならびにそれを合成及び使用する方法
WO2025119279A1 (zh) 一种ikzf1降解剂及其制备方法和应用